StockData
Mesoblast Ltd logo

Mesoblast Ltd (MESO) stock

MESONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as MEOBF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Aug 27, 2026Score 6/30
$11.91−0.54 (-4.34%)

Close on Nov 17, 2026Market cap $1.54BP/E –Yield –

Mesoblast enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Mesoblast's enterprise value was $1.79B on Nov 11, 2026, against $2.10B a year earlier. Over the last 5 years it ranged from $180.28M to $2.19B, with a median of $631.06M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.79B-18.2%
2025Dec 31, 2025$2.19B+8.6%
2024Dec 31, 2024$2.02B+841.2%
2023Dec 29, 2023$214.50M-49.4%
2022Dec 30, 2022$424.08M-32.8%
2021Dec 31, 2021$631.06M-33.6%
2020Dec 31, 2020$951.08M+18.7%
2019Dec 31, 2019$801.13M+94.1%
2018Dec 31, 2018$412.68M-1.8%
2017Dec 29, 2017$420.32M+36.1%
2016Dec 30, 2016$308.77M–

More Mesoblast figures

See a number that looks wrong?